SCHEMBL2624944

SCHEMBL2624944

CO[C@@H]1CCCC[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL618206 1.00
SCHEMBL7269568 1.00
SCHEMBL28009177 1.00 GSR (0.46)
SCHEMBL7459109 1.00
SCHEMBL2624942 1.00
SCHEMBL7467647 1.00
SCHEMBL2429552 1.00
SCHEMBL7919630 1.00
SCHEMBL3149007 1.00
SCHEMBL8969976 0.97 GSR (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718602-B2 EGFR inhibitors BLUEPRINT MEDICINES CORPORATION (US) 2023-08-08 US disclosed
US-11566332-B2 Electrocatalytic hydrogenation and hydrodeoxygenation of oxygenated and unsaturated organic compounds BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2023-01-31 US disclosed
US-9718825-B2 N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals SANOFI (FR) 2017-08-01 US disclosed
EP-2917185-B1 SULFOXIMINE SUBSTITUTED QUINAZOLINES FOR PHARMACEUTICAL COMPOSITIONS EVOTEC INT GMBH (DE) 2017-05-10 EP disclosed
EP-2970259-B1 N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2016-12-21 EP disclosed
US-20160024097-A1 N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2016-01-28 US disclosed
US-20150008139-A1 Electrocatalytic Hydrogenation and Hydrodeoxygenation of Oxygenated and Unsaturated Organic Compounds BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2015-01-08 US disclosed
WO-2014140065-A1 N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS SANOFI (FR) 2014-09-18 WO disclosed
WO-2013134220-A1 ELECTROCATALYTIC HYDROGENATION AND HYDRODEOXYGENATION OF OXYGENATED AND UNSATURATED ORGANIC COMPOUNDS BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2013-09-12 WO disclosed
US-8163938-B2 Aminocyclohexyl ether compounds and uses thereof CARDIOME PHARMA CORP. (CA) 2012-04-24 US disclosed
US-20070254945-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF CARDIOME PHARMA CORP. (CA) 2007-11-01 US disclosed
US-20070099983-A1 Aminocyclohexyl ether compounds and uses thereof CARDIOME PHARMA CORP. (CA) 2007-05-03 US disclosed
EP-0768288-B1 Process for preparing optically active cyclohexanol derivatives TAKASAGO PERFUMERY CO LTD (JP) 2003-01-02 EP disclosed
US-5756863-A Process for preparing optically active cyclohexanol derivatives TAKASAGO INTERNATIONAL CORPORATION (JP) 1998-05-26 US disclosed
EP-0768288-A2 Process for preparing optically active cyclohexanol derivatives Takasago International Corporation (JP) 1997-04-16 EP disclosed
US-4816452-A ANTIBIOTICS BEECHAM GROUP P.L.C. (GB) 1989-03-28 US disclosed
EP-0210815-A2 6-Beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use BEECHAM GROUP PLC (GB) 1987-02-04 EP disclosed
US-4282388-A HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1981-08-04 US disclosed
EP-0002214-B1 BENZYL ETHERS OF CYCLIC 1,2-DIOLS, METHODS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES BAYER AG (DE) 1981-05-13 EP disclosed
EP-0002214-A1 Benzyl ethers of cyclic 1,2-diols, methods for their preparation and their use as herbicides BAYER AG (DE) 1979-06-13 EP disclosed